Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models

PLoS ONE - United States
doi 10.1371/journal.pone.0010108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Phosphodiesterase Type 5 Inhibitors in the Treatment of Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

AB030. Evolution of Phosphodiesterase Type 5 Inhibitors

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Phosphodiesterase Type 5 Inhibitors: A Biochemical and Clinical Correlation Survey

International Journal of Impotence Research
Urology
2003English

Quantitative Risk-Benefit Analysis of Oral Phosphodiesterase Type 5 Inhibitors on Erectile Dysfunction Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Distal Ureteral Calculi of 5 to 10 Mm in Size: A Systematic Review and Network Meta‐analysis

Kaohsiung Journal of Medical Sciences
Medicine
2019English

Phosphodiesterase-5 Inhibitors: Emerging Nephroprotective Drugs

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2015English

AB085. Systematic Review and Meta-Analysis of Phosphodiesterase Type 5 Inhibitors for the Treatment of Female Sexual Dysfunction

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Daily Use of Phosphodiesterase Type 5 Inhibitors as Prevention for Recurrent Priapism

Revista da Associacao Medica Brasileira
Medicine
2017English

Metastatic Brain Tumor.

Nippon Ika Daigaku Zasshi
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy